Casdin Capital, LLC Singular Genomics Systems, Inc. Transaction History

Casdin Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.37 - $0.99 $8,079 - $21,618	-21,837 Reduced 1.62%	1,323,885 $503,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $4.73 $1.2 Million - $2.27 Million	480,000 Added 55.45%	1,345,722 $3.36 Million
Q2 2022 Aug 15, 2022	SELL	$2.86 - $6.44 $1.65 Million - $3.72 Million	-577,148 Reduced 40.0%	865,722 $3.31 Million
Q4 2021 Feb 14, 2022	SELL	$10.45 - $16.9 $13.1 Million - $21.1 Million	-1,250,000 Reduced 46.42%	1,442,870 $16.7 Million
Q2 2021 Aug 16, 2021	BUY	$23.16 - $31.17 $62.4 Million - $83.9 Million	2,692,870 New	2,692,870 $74 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.4B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.